Trials / Completed
CompletedNCT05668819
Efficacy and Safety of Digital Therapeutic in Adults With Prediabetes
Open-Label, Randomized, Controlled, Parallel Group Study Evaluating Efficacy and Safety of Digital Therapeutic (TH-001) for the Treatment of Prediabetes in Adults
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 68 (actual)
- Sponsor
- Tesu Saglik Teknolojileri A.S. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study aims to evaluate the efficacy and safety of a digital therapeutic (TH-001) for adult individuals with prediabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | TH-001 | TH001 is a software program intended to treat adults with prediabetes. |
Timeline
- Start date
- 2023-02-07
- Primary completion
- 2024-12-24
- Completion
- 2024-12-24
- First posted
- 2022-12-30
- Last updated
- 2025-01-10
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05668819. Inclusion in this directory is not an endorsement.